Content about Becton Dickinson and Co.

November 13, 2013

Medical supplies manufacturer BD has joined an organization focused on patient safety, the company said Wednesday.

FRANKLIN LAKES, N.J. — Medical supplies manufacturer BD has joined an organization focused on patient safety, the company said Wednesday.

BD, also known as Becton, Dickinson and Co., announced that it joined the National Patient Safety Foundation's corporate council, a move that it said would enable it to work alongside the NPSF and constituent groups, including healthcare providers, other service and product providers and patients and family representatives to raise awareness of patient safety issues and find solutions for them.

November 4, 2013

The Food and Drug Administration has approved a new injectable painkiller made by Becton, Dickinson and Co., the medical products manufacturer said Monday.

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a new injectable painkiller made by Becton, Dickinson and Co., the medical products manufacturer said Monday.

BD announced the FDA approval of morphine sulfate injection as part of its BD Simplist line of ready-to-administer pre-filled injectables. The drug was approved in the 2-mg-per-mL, 4-mg-per-mL, 5-mg-per-mL, 8-mg-per-mL and 10-mg-per-mL strengths.

September 27, 2013

Becton, Dickinson and Co. is partnering with the World Health Organization in an effort to address maternal and newborn mortality, BD said Friday.

FRANKLIN LAKES, N.J. — Becton, Dickinson and Co. is partnering with the World Health Organization in an effort to address maternal and newborn mortality, BD said Friday.

July 8, 2013

Medical products manufacturer Becton, Dickinson and Co. has appointed Christopher Reidy as its CFO, the company, more commonly known as BD, said Monday.

FRANKLIN LAKES, N.J. — Medical products manufacturer Becton, Dickinson and Co. has appointed Christopher Reidy as its CFO, the company, more commonly known as BD, said Monday.

BD said Reidy, who will also assume the position of EVP administration on July 15, will report to chairman, CEO and president Vincent Forlenza. Reidy replaces Suketu Upadhyay, who has served as acting CFO since November 2012. Upadhyay will become SVP finance, also effective July 15.

June 21, 2013

Becton, Dickinson and Co. has launched a needle that it said would make insulin injections easier and faster for people with diabetes.

FRANKLIN LAKES, N.J. — Becton, Dickinson and Co. has launched a needle that it said would make insulin injections easier and faster for people with diabetes.

BD subsidiary BD Medical announced Friday the BD Ultra-Fine Nano 4-millimeter pen needle. The needle includes technology called EasyFlow, designed to aid faster and more comfortable injections, and product demonstrations will take place at the American Diabetes Association's 73rd annual Scientific Sessions in Chicago, lasting through next Tuesday.

June 3, 2013

Becton, Dickinson and Co. division BD Medical has launched a new prefillable glass syringe designed for biotech drugs.

FRANKLIN LAKES, N.J. — Becton, Dickinson and Co. division BD Medical has launched a new prefillable glass syringe designed for biotech drugs.

The medical supplies manufacturer announced Monday the launch of BD Neopak, which it said was designed to address industry challenges in developing, manufacturing and marketing biologics to patients, saying it would provide a higher level of quality and enhanced container and device integration. The company noted that seven of the top-10 drugs worldwide and more than half the drugs in development were biologics.

April 23, 2013

The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

FRANKLIN LAKES, N.J. — The Food and Drug Administration has approved a second product in BD's new line of injectable drugs, the company said Tuesday.

BD Rx, the pharmaceutical arm of the medical technology manufacturer, whose name stands for Becton, Dickinson and Co., received FDA approval for metoclopramide, part of its BD Simplist line of ready-to-administer pre-filled generic injectables. The product is an antiemetic, a drug used to stop vomiting.

July 25, 2012

A division of Becton, Dickinson and Co. has introduced a thin-walled needle for injecting highly viscous drug formulations.

FRANKLIN LAKES, N.J. — A division of Becton, Dickinson and Co. has introduced a thin-walled needle for injecting highly viscous drug formulations.

BD Medical announced Wednesday the introduction of the BD Hyflow needle, calling it an alternative to larger needles that could be more painful for patients receiving the highly viscous drugs that are becoming more common in drug pipelines. The Hyflow is a 27-gauge needle designed for use with BD's prefillable syringe systems that increases flow to facilitate use with auto injectors and infusers.

August 17, 2011

Becton, Dickinson and Co. now owns the manufacturer of the PhaSeal system.

FRANKLIN LAKES, N.J. — Becton, Dickinson and Co. now owns the manufacturer of the PhaSeal system.

BD said it has completed its acquisition of Sweden-based Carmel Pharma. Through the deal, BD now owns Carmel's PhaSeal, a leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.

August 15, 2011

BD Medical has launched a line of syringes designed to address medication delivery needs while benefiting the environment, the company said Monday.

FRANKLIN LAKES, N.J. — BD Medical has launched a line of syringes designed to address medication delivery needs while benefiting the environment, the company said Monday.

July 7, 2011

A global medical technology company has appointed a worldwide director of scientific affairs for its diagnostic systems division.

SPARKS, Md. — A global medical technology company has appointed a worldwide director of scientific affairs for its diagnostic systems division.

Becton, Dickinson and Co. said that Patrick Murray has joined its BD Diagnostics segment. In his new role, Murray "will leverage his clinical expertise to best define new product requirements, evaluate new technologies and engage external experts and institutions in BD's innovation process," the company said.